Fortis Healthcare — 360° view

Fortis Healthcare, a company in the Hospital industry, reported revenue of ₹2,735 crore and net profit of ₹320 crore for the September 2026 quarter.

Fortis Healthcare (NSE: FORTIS) closed at ₹825.00 on 20 Nov 2026, down 11.8% over the past year. Its market capitalisation is ₹62,284 crore and it trades at 58.0 times earnings.

Share price
₹825.00 (20 Nov 2026)
Market cap
₹62,284 Cr (20 Nov 2026)
P/E
58.05 (20 Nov 2026)
Revenue
₹2,735 Cr (September 2026 quarter)
Net profit
₹320 Cr (September 2026 quarter)
ROCE
13.4% (FY26)
ROE
11.2% (FY26)
Book value
₹139 (FY26)
Dividend yield
0.12% (last 12 months to 20 Nov 2026)
52-week high / low
₹1,010.10 / ₹704.95 (20 Nov 2026)
1-year return
-11.8% (to 20 Nov 2026)
Sector
Healthcare
Industry
Hospital
Symbol
NSE: FORTIS

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.